Global Clinical Decision Support Systems Market – Industry Trends and Forecast to 2031

임상 의사 결정 지원 시스템 시장 분석 및 규모

임상 의사 결정 지원 시스템 시장에서 고급 AI 알고리즘의 통합은 환자 치료에 혁명을 일으키고 있습니다. 머신 러닝 기반 예측 분석 과 같은 혁신은 실시간 통찰력을 제공하여 진단 및 치료 계획을 개선합니다. 이러한 역동적인 진화는 의료 결과를 개선하는 데 있어 지능형 기술의 중요성이 커지고 있음을 강조합니다.                                

Data Bridge Market Research는 2023년에 57억 8천만 달러였던 글로벌 임상 의사결정 지원 시스템 시장이 2031년까지 215억 7천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 17.9%의 CAGR을 보일 것으로 분석했습니다. 이는 시장 가치를 나타냅니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화

시장 정의

임상 의사 결정 지원 시스템(CDSS)은 의료 전문가가 환자 치료에 대한 정보에 입각한 의사 결정을 내리는 데 도움이 되는 컴퓨터 기반 도구입니다. 이는 환자 데이터를 의료 지식과 통합하여 진단, 치료 및 관리에 대한 권장 사항을 제공하여 오류를 줄이고 환자 결과를 개선하는 동시에 의료 제공의 정확성과 효율성을 개선합니다.            

글로벌 임상 의사 결정 지원 시스템 시장 역학

운전자

• 인공 지능과 머신 러닝의 발전

AI와 머신 러닝을 CDSS에 통합하면 환자 데이터 분석이 향상되고, 개인화된 치료 통찰력을 제공하며 임상적 의사 결정이 개선됩니다. 이러한 발전은 의료 서비스 제공자에게 정확하고 데이터 중심의 권장 사항을 제공하여 궁극적으로 보다 맞춤화되고 효율적인 방식으로 치료 품질과 환자 결과를 향상시킵니다.

• 전자 건강 기록(EHR) 채택 증가

전자 건강 기록(EHR)의 광범위한 수용은 임상 의사 결정 지원 시스템(CDSS)을 임상 워크플로에 원활하게 통합하기 위한 견고한 기반을 구축합니다. 이를 통해 의료 서비스 제공자는 환자 데이터에 손쉽게 액세스하여 치료 시점에서 실시간 의사 결정 지원을 용이하게 하고 궁극적으로 임상 의사 결정의 질과 효율성을 향상시킵니다.

기회

• 원격 진료 및 원격 환자 모니터링 확대

원격 진료 및 원격 환자 모니터링의 급증은 CDSS가 특히 원격 또는 서비스가 부족한 지역에서 가상 상담, 원격 진단 및 지속적인 건강 데이터 추적을 강화할 수 있는 길을 제공합니다. CDSS 통합은 의료 접근성을 향상시켜 효율적인 치료 제공 및 정보에 입각한 의사 결정을 가능하게 하여 다양한 환경에서 의료 접근성의 격차를 해소하고 환자 결과를 개선합니다.

• 만성 질환 부담 증가

당뇨병, 심혈관 질환, 암과 같은 만성 질환의 유병률이 증가함에 따라 임상 의사 결정 지원 시스템(CDSS)이 필수적임을 강조합니다. 이러한 도구는 의료 서비스 제공자가 복잡한 환자 사례를 탐색하고 치료 전략을 개선하여 전 세계적으로 이러한 질병을 관리하는 데 따른 복잡성을 해결하는 데 도움이 됩니다. 

제약/도전

• 개인정보 보호 및 보안에 대한 우려

Privacy and security concerns, coupled with regulatory compliance such as HIPAA, impose significant complexities and costs on clinical decision support systems (CDSS) providers. Ensuring patient data confidentiality and safeguarding against breaches require robust measures, deterring some potential adopters due to heightened risks and the resources needed for compliance, thereby hindering market expansion. 

• Issue in Data Quality and Interoperability

Inadequate data quality and interoperability standards across healthcare IT systems undermine the market for clinical decision support systems (CDSS). Without reliable data inputs and seamless integration capabilities, CDSS struggle to deliver accurate and timely insights, diminishing their perceived value and adoption by healthcare providers. This hampers market growth and limits CDSS implementation across healthcare organizations. 

This global clinical decision support systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global clinical decision support systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In June 2022, nView Health launched a clinical decision support solution, contributing to the growth of the clinical decision support systems market. This solution employs a comprehensive model for mental illness assessment, treatment, and monitoring, aligning with the market's emphasis on measurement-based care processes
• In August 2022, Change Healthcare launched InterQual 2022, bolstering the clinical decision support systems market with updated evidence-based criteria and technology. This advancement aligns with market trends focusing on optimizing clinical decision-making processes through advanced support solutions
• In April 2021, Change Healthcare launched InterQual 2021, fortifying the clinical decision support systems market with its flagship solution. This release, featuring enhanced Medicare criteria and updated content addressing COVID-19 challenges, underscores the market's evolution towards comprehensive decision support tools
• In May 2020, DHIndia, in collaboration with EHRC@IIITB & Healthelife, announced the development of a CDSS for COVID-19 screening, driving innovation in the clinical decision support systems market. This partnership also facilitated the creation of a triage application, reflecting market trends prioritizing frontline healthcare support systems

Global Clinical Decision Support Systems Market Scope

The global clinical decision support systems market is segmented on the basis of component, product, type, model, delivery mode, application, level of interactivity, and patient care setting. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Component

• Services
• Software
• Hardware

Delivery Mode

• Web-Based
• On Premise
• Cloud Based

Product

• Standalone CDSS
• Integrated CPOE with CDSS
• Integrated EHR with CDSS
• Integrated CDSS with CPOE and EHR

Application

• Advanced CDSS
• Conventional CDSS
• Drug-drug interactions
• Drug Allergy Alerts
• Clinical Reminders
• Clinical Guidelines
• Drug Dosing Support

Model

• Knowledge Based
• Non-Knowledge Based

Type

• Therapeutic
• Diagnostic

 Level of Interactivity

• Active
• Passive

Patient Care Setting

• In Patient
• Ambulatory Care Settings

Global Clinical Decision Support Systems Market Regional Analysis/Insights

The global clinical decision support systems market is analysed and market size insights and trends are provided by component, product, type, model, delivery mode, application, level of interactivity and patient care setting as referenced above.

The countries covered in the global clinical decision support systems market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific , Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the global clinical decision support systems market due to rising demand for healthcare IT solutions. Rapid technical advancements and a focus on healthcare service value further propel growth in the region, promising sustained expansion ahead.

Asia Pacific is expected to observe significant growth in the global clinical decision support systems market due to its large elderly population, enhanced government regulation, high burden of chronic diseases, and increasing focus of market players on advancing nations, driving market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global clinical decision support systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global clinical decision support systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global clinical decision support systems market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Clinical Decision Support Systems Market Share Analysis

The global clinical decision support systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the global clinical decision support systems market are:

• Oracle (U.S.)
• Siemens Healthineers AG (Germany)
• MCKESSON CORPORATION (U.S.)
• Epic Systems Corporation (U.S.)
• Medical Information Technology, Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Wolters Kluwer N.V. (Netherlands)
• Hearst Communications, Inc. (U.S.)
• Change Healthcare (U.S.)
• VisualDx (U.S.)
• GIDEON Informatics, Inc. (U.S.)
• Evidera (U.S.)
• EBSCO Industries, Inc. (U.S.)
• 3M (U.S.)
• Promantra (U.S.)

SKU-36663